ARI Orthopaedics 2027 – Bone And Fracture Repair

Bone diseases and impaired fracture healing continue to pose significant clinical challenges.

Advances in senescence targeting, extracellular vesicles, chondroprogenitor mobilization, innovative biomaterials, osteoimmunology, as well as microRNA-based diagnostics and therapies are fundamentally transforming regenerative orthopaedics. These innovations are paving the way for improved patient selection and more effective management of bone diseases and delayed or non-union fracture healing.

This year’s conference will highlight these groundbreaking developments and demonstrate how innovative strategies are bringing us closer than ever to successful clinical translation. The conference topics will contribute to a deeper understanding of musculoskeletal regeneration and address the urgent need for stronger collaboration between scientists and clinicians.